SufS is integral to bacterial pathogenesis:
Fe-S Cluster Biogenesis: SufS mobilizes sulfur from cysteine to synthesize Fe-S clusters, which are cofactors for enzymes involved in DNA repair, electron transport, and redox regulation .
Virulence Regulation: The sufABCDSE operon, regulated by the transcription factor IscR, is essential for the activity of the type III secretion system (T3SS), a key virulence machinery enabling Yersinia to suppress host immune responses .
Stress Adaptation: SufS supports bacterial survival under host-induced oxidative stress and iron starvation during infection .
Operon Conservation: The suf operon is conserved in Y. pseudotuberculosis and Y. pestis, with IscR binding sites showing >93% conservation between these species .
T3SS Dependency: Deletion of suf genes abolishes T3SS activity, impairing bacterial ability to inject effector proteins into host cells .
Cloning: The sufS gene (lacking its signal sequence) was cloned into the pET32b(+) vector and expressed in E. coli BL21(DE3) under IPTG induction .
Purification: The protein was isolated from inclusion bodies using ion-exchange and gel-filtration chromatography, followed by refolding in Triton X-100 .
Drug Target: SufS is a potential target for antimicrobials, as Fe-S cluster biogenesis is vital for bacterial survival .
Biochemical Studies: Recombinant SufS enables in vitro studies of Fe-S cluster assembly mechanisms .
Comparative Pathogenesis: Research on SufS informs evolutionary studies of Yersinia species, including Y. pestis .
Key studies and resources include:
KEGG: ypb:YPTS_2384
Yersinia pseudotuberculosis is a Gram-negative bacterium belonging to the Yersiniaceae family within the order Enterobacterales. It causes Far East scarlet-like fever in humans, characterized by fever, abdominal pain (often mimicking appendicitis), and occasionally skin complaints such as erythema nodosum . Unlike typical Y. enterocolitica infections, diarrhea is often absent, making diagnosis challenging. The infection, which typically lasts 1-3 weeks without treatment, is zoonotically transmitted through the food-borne route, particularly from undercooked pork products .
SufS is a pyridoxal 5'-phosphate (PLP)-dependent type II cysteine desulfurase that plays a crucial role in the SUF (sulfur utilization factor) pathway for iron-sulfur (Fe-S) cluster biogenesis . The enzyme mobilizes sulfur from L-cysteine to generate alanine and a protein-bound persulfide intermediate. This persulfide can then be transferred to a sulfur acceptor protein (SufE in E. coli or SufU in Gram-positive bacteria), which subsequently delivers the sulfur for Fe-S cluster assembly on the scaffold proteins . Fe-S clusters are essential cofactors for numerous proteins involved in key cellular processes including electron transport, enzymatic catalysis, and sensing environmental conditions .
The SUF pathway is one of three major systems for Fe-S cluster biogenesis in bacteria, alongside the ISC (iron-sulfur cluster) and NIF (nitrogen fixation) systems. While ISC is the primary housekeeping system in many bacteria under normal conditions, the SUF system is typically activated under oxidative stress and iron limitation conditions, such as those encountered during infection . Unlike the ISC system which uses IscS as its cysteine desulfurase, the SUF system employs SufS, which generally has lower intrinsic activity but is activated through interaction with its partner protein SufE or SufU . This activation mechanism may allow for tighter regulation of sulfur mobilization during stress conditions.
While the specific crystal structure of Y. pseudotuberculosis SufS has not been detailed in the provided search results, comparative analysis with other bacterial SufS proteins suggests it is a homodimeric PLP-dependent enzyme . Each monomer contains a PLP cofactor covalently linked to a conserved lysine residue through a Schiff base (internal aldimine). The active site includes a conserved cysteine residue that forms the protein-bound persulfide intermediate during the catalytic cycle. Based on structural studies of SufS from other organisms, the protein likely contains a more buried active site cysteine compared to other cysteine desulfurases like IscS, which contributes to its lower intrinsic activity and requirement for activation by partner proteins .
In Y. pseudotuberculosis, SufS interacts with other proteins in the SUF pathway encoded by the sufABCDSE operon . Particularly important is its interaction with SufE, which acts as a sulfur acceptor. The transfer of the persulfide from SufS to SufE enhances the catalytic efficiency of SufS by alleviating product inhibition and preventing non-specific reactions of the highly reactive persulfide intermediate . The SufBCD complex, which serves as the scaffold for Fe-S cluster assembly, has also been shown to further stimulate SufS activity in E. coli . These protein-protein interactions ensure the efficient and specific transfer of sulfur for Fe-S cluster formation while minimizing the release of toxic free sulfide into the cellular environment.
Based on studies with SufS from other bacterial species, E. coli-based expression systems are typically effective for producing recombinant SufS proteins . The pET expression system using E. coli BL21(DE3) or its derivatives is commonly employed due to its tight regulation and high expression levels. The SufS gene can be cloned with an N-terminal or C-terminal affinity tag (such as His6, GST, or MBP) to facilitate purification. Expression is typically induced at lower temperatures (16-25°C) to enhance protein solubility and proper folding. Supplementation with pyridoxal 5'-phosphate (PLP) in the growth medium or during protein purification may improve the cofactor loading of the recombinant enzyme .
A typical purification protocol for His-tagged recombinant SufS includes:
Cell lysis by sonication or French press in a buffer containing:
50 mM Tris-HCl or HEPES, pH 7.5-8.0
300 mM NaCl
5-10% glycerol
1 mM DTT or 2-mercaptoethanol
Protease inhibitor cocktail
Immobilized metal affinity chromatography (IMAC) using Ni-NTA or Co-TALON resin
Size exclusion chromatography to remove aggregates and ensure homogeneity
Optional ion exchange chromatography for higher purity
Throughout purification, maintaining reducing conditions (1-5 mM DTT or 2-mercaptoethanol) helps preserve the activity of the cysteine residues. Addition of 10-50 μM PLP during purification can ensure full cofactor loading . The purified protein typically appears yellow due to the PLP cofactor, and its spectroscopic properties (absorbance maximum at around 420 nm) can be used to assess cofactor incorporation.
Several complementary assays can be used to characterize the activity of recombinant SufS:
A. Methylene blue assay for sulfide production:
This assay measures the formation of methylene blue from N,N-dimethyl-p-phenylenediamine and FeCl₃ in the presence of H₂S generated from the reaction. While simple, this assay requires a strong reductant (DTT) to cleave the enzyme-bound persulfide, which may not reflect the physiological mechanism.
B. Alanine production assay:
Quantification of alanine formation using HPLC, coupled enzyme assays, or commercially available kits provides a direct measure of the cysteine desulfurase reaction. This approach can be used for both steady-state and pre-steady-state kinetic analyses .
C. Persulfide formation assay:
Detection of protein-bound persulfides using specific alkylating agents and mass spectrometry allows for direct monitoring of this key intermediate. Techniques using fluorescent or colorimetric probes for persulfide detection have also been developed .
D. Coupled SufE/SufU stimulation assay:
Measuring the enhancement of SufS activity in the presence of its partner protein (SufE or SufU) provides insights into the physiologically relevant persulfide transfer mechanism .
Based on studies with SufS enzymes from other organisms:
| Parameter | E. coli SufS | B. subtilis SufS | Expected range for Y. pseudotuberculosis SufS |
|---|---|---|---|
| kcat (min⁻¹) | 0.3-2.0 | 1.0-5.0 | 0.3-5.0 |
| Km for L-cysteine (mM) | 0.02-0.1 | 0.01-0.05 | 0.01-0.1 |
| Stimulation by SufE/SufU | 8-32 fold | 15-fold | 8-32 fold |
| pH optimum | 7.5-8.5 | 8.0-9.0 | 7.5-9.0 |
Y. pseudotuberculosis SufS would likely exhibit kinetic parameters similar to those of E. coli SufS, given their closer phylogenetic relationship. The enzyme is expected to show half-sites reactivity (as observed for E. coli SufS), where only one monomer in the dimer is active at a time, with a burst phase amplitude of approximately 0.4-0.5 equivalents per dimer . The rate-limiting step in the absence of SufE is likely to be persulfide cleavage or release, with stimulation by SufE primarily affecting this step rather than the initial cysteine desulfuration reaction .
SufS plays a critical role in Y. pseudotuberculosis virulence through several mechanisms:
Support of T3SS functionality: The SufS-dependent Fe-S cluster biogenesis pathway is required for the activity of the Ysc type III secretion system (T3SS), a major virulence determinant in Yersinia . This suggests that one or more proteins in the T3SS require Fe-S clusters for their function.
Response to iron limitation: During infection, iron limitation is a key host defense mechanism. SufS activity is critical for bacterial adaptation to this stress condition, enabling continued synthesis of essential Fe-S cluster proteins despite restricted iron availability .
Integration with virulence regulation networks: The expression of sufS and the suf operon is regulated by IscR, a transcription factor that responds to iron availability and coordinates the expression of multiple virulence factors in Y. pseudotuberculosis . IscR binding sites have been identified upstream of the suf operon and numerous virulence-associated genes, suggesting a coordinated regulation of metabolism and virulence .
Protection against oxidative stress: The SUF system, including SufS, provides protection against oxidative stress encountered during host-pathogen interactions, particularly within phagocytic cells .
SufS expression is regulated in response to several environmental signals relevant to infection:
Data from chromatin immunoprecipitation sequencing (ChIP-Seq) and RNA sequencing (RNA-Seq) of Y. pseudotuberculosis have identified IscR binding sites in the promoter regions of genes involved in iron homeostasis, reactive oxygen species metabolism, and cell envelope remodeling, in addition to the suf operon . This suggests that SufS expression is coordinated with multiple stress response and virulence pathways.
Site-directed mutagenesis can address several key questions about Y. pseudotuberculosis SufS function:
Catalytic residues: Mutations of the conserved active site cysteine that forms the persulfide (typically Cys364 based on homology with E. coli SufS) would be expected to abolish activity. Mutations of residues involved in PLP binding, substrate binding, or protein-protein interactions can provide insights into their specific roles.
SufE/SufU interaction interface: Mutations at the predicted interface with SufE or SufU can elucidate the molecular basis for the stimulation of SufS activity by these partner proteins.
Half-sites reactivity: Mutations designed to disrupt communication between the two active sites of the SufS dimer can help understand the molecular basis for the observed half-sites reactivity .
A systematic approach would involve:
In silico identification of conserved residues through multiple sequence alignment
Generation of point mutants using PCR-based techniques
Expression and purification of mutant proteins
Comprehensive biochemical characterization comparing wild-type and mutant properties
Structural studies (if possible) to identify conformational changes
Given the importance of SufS for Y. pseudotuberculosis virulence, particularly under the iron-limited conditions encountered during infection , it represents a potential target for novel antimicrobial strategies:
Inhibitor development: High-throughput screening of chemical libraries against recombinant SufS could identify specific inhibitors. Crystal structures (if available) could guide structure-based drug design targeting the active site or protein-protein interaction interfaces.
Attenuated vaccine development: Y. pseudotuberculosis strains with modified sufS could potentially serve as live attenuated vaccine candidates, not only against Y. pseudotuberculosis infection but possibly also against Y. pestis, given their close genetic relationship .
Diagnostic applications: Antibodies against unique epitopes of Y. pseudotuberculosis SufS could be developed for specific detection of this pathogen in clinical samples .
Broad-spectrum targeting: Comparison of SufS across multiple pathogens could identify conserved features for broader antimicrobial development, especially against bacteria that rely heavily on the SUF system as their primary Fe-S cluster biogenesis pathway.
Systems biology approaches can provide a more comprehensive understanding of SufS function in the context of Y. pseudotuberculosis metabolism and virulence:
Recent studies have already begun to elucidate the tight connection between pathogenicity and core metabolism in Y. pseudotuberculosis through integrated transcriptome and 13C-fluxome analysis , providing a framework for similar approaches focused specifically on the role of SufS.